nodes	percent_of_prediction	percent_of_DWPC	metapath
Ethinyl Estradiol—AOX1—Methotrexate—muscle cancer	0.158	0.18	CbGbCtD
Ethinyl Estradiol—ABCB11—Vincristine—muscle cancer	0.15	0.171	CbGbCtD
Ethinyl Estradiol—ABCB11—Doxorubicin—muscle cancer	0.0935	0.107	CbGbCtD
Ethinyl Estradiol—ABCC2—Vincristine—muscle cancer	0.0786	0.0898	CbGbCtD
Ethinyl Estradiol—ABCC2—Etoposide—muscle cancer	0.072	0.0823	CbGbCtD
Ethinyl Estradiol—ABCC2—Doxorubicin—muscle cancer	0.0491	0.0561	CbGbCtD
Ethinyl Estradiol—ABCC2—Methotrexate—muscle cancer	0.0476	0.0544	CbGbCtD
Ethinyl Estradiol—ABCB1—Dactinomycin—muscle cancer	0.0416	0.0476	CbGbCtD
Ethinyl Estradiol—CYP2C8—Etoposide—muscle cancer	0.0347	0.0396	CbGbCtD
Ethinyl Estradiol—CYP2B6—Doxorubicin—muscle cancer	0.0312	0.0357	CbGbCtD
Ethinyl Estradiol—ABCB1—Vincristine—muscle cancer	0.0256	0.0293	CbGbCtD
Ethinyl Estradiol—ABCB1—Etoposide—muscle cancer	0.0235	0.0268	CbGbCtD
Ethinyl Estradiol—ABCB1—Doxorubicin—muscle cancer	0.016	0.0183	CbGbCtD
Ethinyl Estradiol—ABCB1—Methotrexate—muscle cancer	0.0155	0.0177	CbGbCtD
Ethinyl Estradiol—CYP3A4—Vincristine—muscle cancer	0.0154	0.0175	CbGbCtD
Ethinyl Estradiol—CYP3A4—Etoposide—muscle cancer	0.0141	0.0161	CbGbCtD
Ethinyl Estradiol—CYP3A4—Doxorubicin—muscle cancer	0.0096	0.011	CbGbCtD
Ethinyl Estradiol—SHBG—hindlimb—muscle cancer	0.00556	0.145	CbGeAlD
Ethinyl Estradiol—AOX1—Effects of Nitric Oxide—MB—muscle cancer	0.00379	0.516	CbGpPWpGaD
Ethinyl Estradiol—Cerebral infarction—Vincristine—muscle cancer	0.00305	0.0386	CcSEcCtD
Ethinyl Estradiol—NR1I2—head—muscle cancer	0.00247	0.0643	CbGeAlD
Ethinyl Estradiol—SLC10A1—renal system—muscle cancer	0.00185	0.0481	CbGeAlD
Ethinyl Estradiol—Thromboembolic event—Methotrexate—muscle cancer	0.00179	0.0227	CcSEcCtD
Ethinyl Estradiol—Venous thromboembolism—Doxorubicin—muscle cancer	0.00142	0.018	CcSEcCtD
Ethinyl Estradiol—Menorrhagia—Vincristine—muscle cancer	0.00134	0.017	CcSEcCtD
Ethinyl Estradiol—ESR2—smooth muscle tissue—muscle cancer	0.00128	0.0334	CbGeAlD
Ethinyl Estradiol—SLC10A1—head—muscle cancer	0.00124	0.0322	CbGeAlD
Ethinyl Estradiol—ESR2—renal system—muscle cancer	0.00123	0.0321	CbGeAlD
Ethinyl Estradiol—SLC10A1—testis—muscle cancer	0.00119	0.0311	CbGeAlD
Ethinyl Estradiol—AOX1—renal system—muscle cancer	0.00119	0.0309	CbGeAlD
Ethinyl Estradiol—ABCB11—testis—muscle cancer	0.00118	0.0307	CbGeAlD
Ethinyl Estradiol—ESR1—embryo—muscle cancer	0.00112	0.0291	CbGeAlD
Ethinyl Estradiol—AOX1—cardiac atrium—muscle cancer	0.00106	0.0277	CbGeAlD
Ethinyl Estradiol—Loss of libido—Methotrexate—muscle cancer	0.00104	0.0132	CcSEcCtD
Ethinyl Estradiol—Erythema nodosum—Doxorubicin—muscle cancer	0.000965	0.0122	CcSEcCtD
Ethinyl Estradiol—ABCC2—renal system—muscle cancer	0.000928	0.0242	CbGeAlD
Ethinyl Estradiol—AOX1—tendon—muscle cancer	0.000927	0.0241	CbGeAlD
Ethinyl Estradiol—SHBG—bone marrow—muscle cancer	0.000907	0.0236	CbGeAlD
Ethinyl Estradiol—ESR2—vagina—muscle cancer	0.000894	0.0233	CbGeAlD
Ethinyl Estradiol—Leukorrhea—Doxorubicin—muscle cancer	0.00089	0.0113	CcSEcCtD
Ethinyl Estradiol—ESR1—smooth muscle tissue—muscle cancer	0.000878	0.0228	CbGeAlD
Ethinyl Estradiol—SHBG—vagina—muscle cancer	0.000869	0.0226	CbGeAlD
Ethinyl Estradiol—AOX1—vagina—muscle cancer	0.00086	0.0224	CbGeAlD
Ethinyl Estradiol—ESR1—renal system—muscle cancer	0.000845	0.022	CbGeAlD
Ethinyl Estradiol—Embolism venous—Doxorubicin—muscle cancer	0.000827	0.0105	CcSEcCtD
Ethinyl Estradiol—ESR2—head—muscle cancer	0.000825	0.0215	CbGeAlD
Ethinyl Estradiol—ESR2—testis—muscle cancer	0.000797	0.0208	CbGeAlD
Ethinyl Estradiol—Vaginal discharge—Methotrexate—muscle cancer	0.000792	0.01	CcSEcCtD
Ethinyl Estradiol—SHBG—testis—muscle cancer	0.000775	0.0202	CbGeAlD
Ethinyl Estradiol—AOX1—testis—muscle cancer	0.000768	0.02	CbGeAlD
Ethinyl Estradiol—Local reaction—Doxorubicin—muscle cancer	0.000754	0.00954	CcSEcCtD
Ethinyl Estradiol—Embolism—Methotrexate—muscle cancer	0.000751	0.0095	CcSEcCtD
Ethinyl Estradiol—ABCC2—tendon—muscle cancer	0.000724	0.0189	CbGeAlD
Ethinyl Estradiol—Pain in extremity—Vincristine—muscle cancer	0.000721	0.00913	CcSEcCtD
Ethinyl Estradiol—CYP2C8—renal system—muscle cancer	0.000696	0.0181	CbGeAlD
Ethinyl Estradiol—Enlargement abdomen—Doxorubicin—muscle cancer	0.000694	0.00878	CcSEcCtD
Ethinyl Estradiol—Pelvic pain—Doxorubicin—muscle cancer	0.000686	0.00868	CcSEcCtD
Ethinyl Estradiol—Vaginal discharge—Doxorubicin—muscle cancer	0.000686	0.00868	CcSEcCtD
Ethinyl Estradiol—Embolism—Doxorubicin—muscle cancer	0.00065	0.00823	CcSEcCtD
Ethinyl Estradiol—CYP2B6—renal system—muscle cancer	0.000624	0.0162	CbGeAlD
Ethinyl Estradiol—ESR1—vagina—muscle cancer	0.000612	0.0159	CbGeAlD
Ethinyl Estradiol—ABCC2—testis—muscle cancer	0.0006	0.0156	CbGeAlD
Ethinyl Estradiol—Thrombosis—Doxorubicin—muscle cancer	0.00059	0.00746	CcSEcCtD
Ethinyl Estradiol—Dysuria—Vincristine—muscle cancer	0.000583	0.00738	CcSEcCtD
Ethinyl Estradiol—ESR1—head—muscle cancer	0.000565	0.0147	CbGeAlD
Ethinyl Estradiol—Weight decreased—Vincristine—muscle cancer	0.000564	0.00714	CcSEcCtD
Ethinyl Estradiol—Pharyngitis—Dactinomycin—muscle cancer	0.000554	0.00701	CcSEcCtD
Ethinyl Estradiol—Depression—Vincristine—muscle cancer	0.000554	0.00701	CcSEcCtD
Ethinyl Estradiol—Acute coronary syndrome—Vincristine—muscle cancer	0.000548	0.00693	CcSEcCtD
Ethinyl Estradiol—ESR1—testis—muscle cancer	0.000546	0.0142	CbGeAlD
Ethinyl Estradiol—Myocardial infarction—Vincristine—muscle cancer	0.000545	0.0069	CcSEcCtD
Ethinyl Estradiol—Neuropathy peripheral—Vincristine—muscle cancer	0.000545	0.0069	CcSEcCtD
Ethinyl Estradiol—Erythema multiforme—Dactinomycin—muscle cancer	0.000528	0.00668	CcSEcCtD
Ethinyl Estradiol—Herpes simplex—Methotrexate—muscle cancer	0.000523	0.00662	CcSEcCtD
Ethinyl Estradiol—CYP2C8—vagina—muscle cancer	0.000504	0.0131	CbGeAlD
Ethinyl Estradiol—Hypoaesthesia—Vincristine—muscle cancer	0.000496	0.00628	CcSEcCtD
Ethinyl Estradiol—Alopecia—Dactinomycin—muscle cancer	0.000493	0.00625	CcSEcCtD
Ethinyl Estradiol—Urinary tract disorder—Vincristine—muscle cancer	0.000493	0.00624	CcSEcCtD
Ethinyl Estradiol—Connective tissue disorder—Vincristine—muscle cancer	0.00049	0.00621	CcSEcCtD
Ethinyl Estradiol—Urethral disorder—Vincristine—muscle cancer	0.000489	0.00619	CcSEcCtD
Ethinyl Estradiol—Vaginal inflammation—Methotrexate—muscle cancer	0.000482	0.0061	CcSEcCtD
Ethinyl Estradiol—Breast pain—Doxorubicin—muscle cancer	0.000478	0.00606	CcSEcCtD
Ethinyl Estradiol—Amenorrhoea—Doxorubicin—muscle cancer	0.000475	0.00601	CcSEcCtD
Ethinyl Estradiol—CYP3A4—renal system—muscle cancer	0.000471	0.0123	CbGeAlD
Ethinyl Estradiol—Cystitis noninfective—Methotrexate—muscle cancer	0.000471	0.00596	CcSEcCtD
Ethinyl Estradiol—Cystitis—Methotrexate—muscle cancer	0.000465	0.00589	CcSEcCtD
Ethinyl Estradiol—Vaginal infection—Methotrexate—muscle cancer	0.000455	0.00576	CcSEcCtD
Ethinyl Estradiol—Herpes simplex—Doxorubicin—muscle cancer	0.000453	0.00573	CcSEcCtD
Ethinyl Estradiol—Angiopathy—Vincristine—muscle cancer	0.000452	0.00573	CcSEcCtD
Ethinyl Estradiol—CYP2B6—vagina—muscle cancer	0.000452	0.0118	CbGeAlD
Ethinyl Estradiol—Ill-defined disorder—Dactinomycin—muscle cancer	0.000451	0.00571	CcSEcCtD
Ethinyl Estradiol—Infestation NOS—Etoposide—muscle cancer	0.00045	0.0057	CcSEcCtD
Ethinyl Estradiol—Infestation—Etoposide—muscle cancer	0.00045	0.0057	CcSEcCtD
Ethinyl Estradiol—CYP2C8—testis—muscle cancer	0.00045	0.0117	CbGeAlD
Ethinyl Estradiol—Acute coronary syndrome—Etoposide—muscle cancer	0.000444	0.00562	CcSEcCtD
Ethinyl Estradiol—Neuropathy peripheral—Etoposide—muscle cancer	0.000441	0.00559	CcSEcCtD
Ethinyl Estradiol—Myocardial infarction—Etoposide—muscle cancer	0.000441	0.00559	CcSEcCtD
Ethinyl Estradiol—ABCB1—embryo—muscle cancer	0.000441	0.0115	CbGeAlD
Ethinyl Estradiol—Alopecia—Vincristine—muscle cancer	0.000441	0.00558	CcSEcCtD
Ethinyl Estradiol—Malaise—Dactinomycin—muscle cancer	0.000438	0.00555	CcSEcCtD
Ethinyl Estradiol—Mental disorder—Vincristine—muscle cancer	0.000437	0.00553	CcSEcCtD
Ethinyl Estradiol—Bladder pain—Methotrexate—muscle cancer	0.000436	0.00552	CcSEcCtD
Ethinyl Estradiol—Neoplasm—Methotrexate—muscle cancer	0.000436	0.00552	CcSEcCtD
Ethinyl Estradiol—Back pain—Vincristine—muscle cancer	0.00042	0.00532	CcSEcCtD
Ethinyl Estradiol—CYP2B6—head—muscle cancer	0.000418	0.0109	CbGeAlD
Ethinyl Estradiol—Vaginal inflammation—Doxorubicin—muscle cancer	0.000417	0.00528	CcSEcCtD
Ethinyl Estradiol—Discomfort—Dactinomycin—muscle cancer	0.000409	0.00518	CcSEcCtD
Ethinyl Estradiol—Cystitis noninfective—Doxorubicin—muscle cancer	0.000408	0.00516	CcSEcCtD
Ethinyl Estradiol—Influenza like illness—Doxorubicin—muscle cancer	0.000405	0.00513	CcSEcCtD
Ethinyl Estradiol—CYP2B6—testis—muscle cancer	0.000404	0.0105	CbGeAlD
Ethinyl Estradiol—Cystitis—Doxorubicin—muscle cancer	0.000403	0.0051	CcSEcCtD
Ethinyl Estradiol—Hypoaesthesia—Etoposide—muscle cancer	0.000402	0.00509	CcSEcCtD
Ethinyl Estradiol—Urinary tract disorder—Etoposide—muscle cancer	0.000399	0.00505	CcSEcCtD
Ethinyl Estradiol—Oedema—Dactinomycin—muscle cancer	0.000397	0.00502	CcSEcCtD
Ethinyl Estradiol—Fluid retention—Doxorubicin—muscle cancer	0.000396	0.00502	CcSEcCtD
Ethinyl Estradiol—Urethral disorder—Etoposide—muscle cancer	0.000396	0.00501	CcSEcCtD
Ethinyl Estradiol—Infection—Dactinomycin—muscle cancer	0.000394	0.00499	CcSEcCtD
Ethinyl Estradiol—Vaginal infection—Doxorubicin—muscle cancer	0.000394	0.00499	CcSEcCtD
Ethinyl Estradiol—Erythema multiforme—Etoposide—muscle cancer	0.000382	0.00484	CcSEcCtD
Ethinyl Estradiol—Eye disorder—Etoposide—muscle cancer	0.000378	0.00478	CcSEcCtD
Ethinyl Estradiol—Bladder pain—Doxorubicin—muscle cancer	0.000377	0.00478	CcSEcCtD
Ethinyl Estradiol—Neoplasm—Doxorubicin—muscle cancer	0.000377	0.00478	CcSEcCtD
Ethinyl Estradiol—Visual disturbance—Methotrexate—muscle cancer	0.000369	0.00467	CcSEcCtD
Ethinyl Estradiol—Angiopathy—Etoposide—muscle cancer	0.000367	0.00464	CcSEcCtD
Ethinyl Estradiol—Immune system disorder—Etoposide—muscle cancer	0.000365	0.00462	CcSEcCtD
Ethinyl Estradiol—Alopecia—Etoposide—muscle cancer	0.000357	0.00452	CcSEcCtD
Ethinyl Estradiol—Cerebrovascular accident—Methotrexate—muscle cancer	0.000357	0.00452	CcSEcCtD
Ethinyl Estradiol—Oedema—Vincristine—muscle cancer	0.000354	0.00449	CcSEcCtD
Ethinyl Estradiol—Infection—Vincristine—muscle cancer	0.000352	0.00446	CcSEcCtD
Ethinyl Estradiol—Nervous system disorder—Vincristine—muscle cancer	0.000347	0.0044	CcSEcCtD
Ethinyl Estradiol—Fatigue—Dactinomycin—muscle cancer	0.000342	0.00433	CcSEcCtD
Ethinyl Estradiol—Back pain—Etoposide—muscle cancer	0.00034	0.00431	CcSEcCtD
Ethinyl Estradiol—Muscle spasms—Etoposide—muscle cancer	0.000338	0.00428	CcSEcCtD
Ethinyl Estradiol—Eczema—Doxorubicin—muscle cancer	0.000337	0.00427	CcSEcCtD
Ethinyl Estradiol—Irritability—Methotrexate—muscle cancer	0.000334	0.00423	CcSEcCtD
Ethinyl Estradiol—ABCB1—renal system—muscle cancer	0.000334	0.00869	CbGeAlD
Ethinyl Estradiol—Mood swings—Methotrexate—muscle cancer	0.000331	0.0042	CcSEcCtD
Ethinyl Estradiol—Feeling abnormal—Dactinomycin—muscle cancer	0.000327	0.00414	CcSEcCtD
Ethinyl Estradiol—Ill-defined disorder—Etoposide—muscle cancer	0.000326	0.00413	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal pain—Dactinomycin—muscle cancer	0.000324	0.00411	CcSEcCtD
Ethinyl Estradiol—Hot flush—Doxorubicin—muscle cancer	0.000324	0.0041	CcSEcCtD
Ethinyl Estradiol—Increased appetite—Doxorubicin—muscle cancer	0.000322	0.00408	CcSEcCtD
Ethinyl Estradiol—Menopausal symptoms—Doxorubicin—muscle cancer	0.000321	0.00406	CcSEcCtD
Ethinyl Estradiol—Malaise—Etoposide—muscle cancer	0.000317	0.00402	CcSEcCtD
Ethinyl Estradiol—Breast disorder—Methotrexate—muscle cancer	0.000316	0.004	CcSEcCtD
Ethinyl Estradiol—Abdominal pain—Dactinomycin—muscle cancer	0.000314	0.00397	CcSEcCtD
Ethinyl Estradiol—Body temperature increased—Dactinomycin—muscle cancer	0.000314	0.00397	CcSEcCtD
Ethinyl Estradiol—Cerebrovascular accident—Doxorubicin—muscle cancer	0.000309	0.00391	CcSEcCtD
Ethinyl Estradiol—Cough—Etoposide—muscle cancer	0.000307	0.00389	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal disorder—Vincristine—muscle cancer	0.000306	0.00387	CcSEcCtD
Ethinyl Estradiol—Fatigue—Vincristine—muscle cancer	0.000305	0.00387	CcSEcCtD
Ethinyl Estradiol—Constipation—Vincristine—muscle cancer	0.000303	0.00384	CcSEcCtD
Ethinyl Estradiol—Pain in extremity—Doxorubicin—muscle cancer	0.000303	0.00384	CcSEcCtD
Ethinyl Estradiol—Migraine—Doxorubicin—muscle cancer	0.000298	0.00377	CcSEcCtD
Ethinyl Estradiol—Affect lability—Doxorubicin—muscle cancer	0.000298	0.00377	CcSEcCtD
Ethinyl Estradiol—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.000297	0.00376	CcSEcCtD
Ethinyl Estradiol—Discomfort—Etoposide—muscle cancer	0.000296	0.00375	CcSEcCtD
Ethinyl Estradiol—Hypersensitivity—Dactinomycin—muscle cancer	0.000292	0.0037	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal pain—Vincristine—muscle cancer	0.00029	0.00367	CcSEcCtD
Ethinyl Estradiol—Mood swings—Doxorubicin—muscle cancer	0.000287	0.00363	CcSEcCtD
Ethinyl Estradiol—Infection—Etoposide—muscle cancer	0.000285	0.00361	CcSEcCtD
Ethinyl Estradiol—Asthenia—Dactinomycin—muscle cancer	0.000285	0.0036	CcSEcCtD
Ethinyl Estradiol—Dysuria—Methotrexate—muscle cancer	0.000283	0.00358	CcSEcCtD
Ethinyl Estradiol—Upper respiratory tract infection—Methotrexate—muscle cancer	0.000281	0.00356	CcSEcCtD
Ethinyl Estradiol—Body temperature increased—Vincristine—muscle cancer	0.00028	0.00355	CcSEcCtD
Ethinyl Estradiol—Abdominal pain—Vincristine—muscle cancer	0.00028	0.00355	CcSEcCtD
Ethinyl Estradiol—Skin disorder—Etoposide—muscle cancer	0.000279	0.00353	CcSEcCtD
Ethinyl Estradiol—Breast disorder—Doxorubicin—muscle cancer	0.000274	0.00347	CcSEcCtD
Ethinyl Estradiol—Diarrhoea—Dactinomycin—muscle cancer	0.000271	0.00344	CcSEcCtD
Ethinyl Estradiol—Infestation NOS—Methotrexate—muscle cancer	0.00027	0.00341	CcSEcCtD
Ethinyl Estradiol—Infestation—Methotrexate—muscle cancer	0.00027	0.00341	CcSEcCtD
Ethinyl Estradiol—Depression—Methotrexate—muscle cancer	0.000269	0.0034	CcSEcCtD
Ethinyl Estradiol—Abdominal distension—Doxorubicin—muscle cancer	0.000264	0.00334	CcSEcCtD
Ethinyl Estradiol—Hypersensitivity—Vincristine—muscle cancer	0.000261	0.00331	CcSEcCtD
Ethinyl Estradiol—Asthenia—Vincristine—muscle cancer	0.000254	0.00322	CcSEcCtD
Ethinyl Estradiol—ABCB1—bone marrow—muscle cancer	0.000252	0.00657	CbGeAlD
Ethinyl Estradiol—Vomiting—Dactinomycin—muscle cancer	0.000252	0.00319	CcSEcCtD
Ethinyl Estradiol—Bronchitis—Doxorubicin—muscle cancer	0.000252	0.00319	CcSEcCtD
Ethinyl Estradiol—Rash—Dactinomycin—muscle cancer	0.00025	0.00317	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal disorder—Etoposide—muscle cancer	0.000248	0.00314	CcSEcCtD
Ethinyl Estradiol—Fatigue—Etoposide—muscle cancer	0.000247	0.00313	CcSEcCtD
Ethinyl Estradiol—Constipation—Etoposide—muscle cancer	0.000245	0.00311	CcSEcCtD
Ethinyl Estradiol—Dysuria—Doxorubicin—muscle cancer	0.000245	0.0031	CcSEcCtD
Ethinyl Estradiol—Upper respiratory tract infection—Doxorubicin—muscle cancer	0.000243	0.00308	CcSEcCtD
Ethinyl Estradiol—Haemoglobin—Methotrexate—muscle cancer	0.000243	0.00308	CcSEcCtD
Ethinyl Estradiol—Diarrhoea—Vincristine—muscle cancer	0.000242	0.00307	CcSEcCtD
Ethinyl Estradiol—Haemorrhage—Methotrexate—muscle cancer	0.000242	0.00306	CcSEcCtD
Ethinyl Estradiol—Pollakiuria—Doxorubicin—muscle cancer	0.000242	0.00306	CcSEcCtD
Ethinyl Estradiol—ABCB1—vagina—muscle cancer	0.000242	0.00629	CbGeAlD
Ethinyl Estradiol—Pharyngitis—Methotrexate—muscle cancer	0.00024	0.00304	CcSEcCtD
Ethinyl Estradiol—Urinary tract disorder—Methotrexate—muscle cancer	0.000239	0.00303	CcSEcCtD
Ethinyl Estradiol—Weight increased—Doxorubicin—muscle cancer	0.000238	0.00302	CcSEcCtD
Ethinyl Estradiol—Urethral disorder—Methotrexate—muscle cancer	0.000237	0.003	CcSEcCtD
Ethinyl Estradiol—Weight decreased—Doxorubicin—muscle cancer	0.000237	0.003	CcSEcCtD
Ethinyl Estradiol—Feeling abnormal—Etoposide—muscle cancer	0.000237	0.00299	CcSEcCtD
Ethinyl Estradiol—Nausea—Dactinomycin—muscle cancer	0.000236	0.00298	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal pain—Etoposide—muscle cancer	0.000235	0.00297	CcSEcCtD
Ethinyl Estradiol—Dizziness—Vincristine—muscle cancer	0.000234	0.00297	CcSEcCtD
Ethinyl Estradiol—Infestation—Doxorubicin—muscle cancer	0.000233	0.00296	CcSEcCtD
Ethinyl Estradiol—Infestation NOS—Doxorubicin—muscle cancer	0.000233	0.00296	CcSEcCtD
Ethinyl Estradiol—Visual impairment—Methotrexate—muscle cancer	0.000233	0.00295	CcSEcCtD
Ethinyl Estradiol—Erythema multiforme—Methotrexate—muscle cancer	0.000229	0.0029	CcSEcCtD
Ethinyl Estradiol—Neuropathy peripheral—Doxorubicin—muscle cancer	0.000229	0.0029	CcSEcCtD
Ethinyl Estradiol—Urticaria—Etoposide—muscle cancer	0.000228	0.00289	CcSEcCtD
Ethinyl Estradiol—Abdominal pain—Etoposide—muscle cancer	0.000227	0.00287	CcSEcCtD
Ethinyl Estradiol—Body temperature increased—Etoposide—muscle cancer	0.000227	0.00287	CcSEcCtD
Ethinyl Estradiol—Urinary tract infection—Doxorubicin—muscle cancer	0.000227	0.00287	CcSEcCtD
Ethinyl Estradiol—Eye disorder—Methotrexate—muscle cancer	0.000226	0.00286	CcSEcCtD
Ethinyl Estradiol—Vomiting—Vincristine—muscle cancer	0.000225	0.00285	CcSEcCtD
Ethinyl Estradiol—Rash—Vincristine—muscle cancer	0.000223	0.00283	CcSEcCtD
Ethinyl Estradiol—ABCB1—head—muscle cancer	0.000223	0.00581	CbGeAlD
Ethinyl Estradiol—Dermatitis—Vincristine—muscle cancer	0.000223	0.00283	CcSEcCtD
Ethinyl Estradiol—Headache—Vincristine—muscle cancer	0.000222	0.00281	CcSEcCtD
Ethinyl Estradiol—Angiopathy—Methotrexate—muscle cancer	0.00022	0.00278	CcSEcCtD
Ethinyl Estradiol—Sinusitis—Doxorubicin—muscle cancer	0.000219	0.00277	CcSEcCtD
Ethinyl Estradiol—Immune system disorder—Methotrexate—muscle cancer	0.000219	0.00277	CcSEcCtD
Ethinyl Estradiol—ESR1—Regulation of nuclear SMAD2/3 signaling—TFE3—muscle cancer	0.000218	0.0296	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—testis—muscle cancer	0.000216	0.00561	CbGeAlD
Ethinyl Estradiol—Alopecia—Methotrexate—muscle cancer	0.000214	0.00271	CcSEcCtD
Ethinyl Estradiol—Mental disorder—Methotrexate—muscle cancer	0.000212	0.00268	CcSEcCtD
Ethinyl Estradiol—Hypersensitivity—Etoposide—muscle cancer	0.000211	0.00268	CcSEcCtD
Ethinyl Estradiol—Malnutrition—Methotrexate—muscle cancer	0.000211	0.00267	CcSEcCtD
Ethinyl Estradiol—Haemoglobin—Doxorubicin—muscle cancer	0.000211	0.00267	CcSEcCtD
Ethinyl Estradiol—Nausea—Vincristine—muscle cancer	0.00021	0.00266	CcSEcCtD
Ethinyl Estradiol—Rhinitis—Doxorubicin—muscle cancer	0.00021	0.00266	CcSEcCtD
Ethinyl Estradiol—Haemorrhage—Doxorubicin—muscle cancer	0.00021	0.00265	CcSEcCtD
Ethinyl Estradiol—Hypoaesthesia—Doxorubicin—muscle cancer	0.000208	0.00264	CcSEcCtD
Ethinyl Estradiol—Pharyngitis—Doxorubicin—muscle cancer	0.000208	0.00263	CcSEcCtD
Ethinyl Estradiol—Urinary tract disorder—Doxorubicin—muscle cancer	0.000207	0.00262	CcSEcCtD
Ethinyl Estradiol—Asthenia—Etoposide—muscle cancer	0.000206	0.00261	CcSEcCtD
Ethinyl Estradiol—Connective tissue disorder—Doxorubicin—muscle cancer	0.000206	0.00261	CcSEcCtD
Ethinyl Estradiol—Urethral disorder—Doxorubicin—muscle cancer	0.000205	0.0026	CcSEcCtD
Ethinyl Estradiol—Back pain—Methotrexate—muscle cancer	0.000204	0.00258	CcSEcCtD
Ethinyl Estradiol—Pruritus—Etoposide—muscle cancer	0.000203	0.00257	CcSEcCtD
Ethinyl Estradiol—Visual impairment—Doxorubicin—muscle cancer	0.000202	0.00256	CcSEcCtD
Ethinyl Estradiol—Erythema multiforme—Doxorubicin—muscle cancer	0.000198	0.00251	CcSEcCtD
Ethinyl Estradiol—Diarrhoea—Etoposide—muscle cancer	0.000196	0.00249	CcSEcCtD
Ethinyl Estradiol—Eye disorder—Doxorubicin—muscle cancer	0.000196	0.00248	CcSEcCtD
Ethinyl Estradiol—Ill-defined disorder—Methotrexate—muscle cancer	0.000195	0.00247	CcSEcCtD
Ethinyl Estradiol—Angiopathy—Doxorubicin—muscle cancer	0.00019	0.00241	CcSEcCtD
Ethinyl Estradiol—Malaise—Methotrexate—muscle cancer	0.00019	0.00241	CcSEcCtD
Ethinyl Estradiol—Dizziness—Etoposide—muscle cancer	0.00019	0.0024	CcSEcCtD
Ethinyl Estradiol—Immune system disorder—Doxorubicin—muscle cancer	0.000189	0.0024	CcSEcCtD
Ethinyl Estradiol—Alopecia—Doxorubicin—muscle cancer	0.000185	0.00234	CcSEcCtD
Ethinyl Estradiol—Cough—Methotrexate—muscle cancer	0.000184	0.00233	CcSEcCtD
Ethinyl Estradiol—Mental disorder—Doxorubicin—muscle cancer	0.000184	0.00232	CcSEcCtD
Ethinyl Estradiol—Vomiting—Etoposide—muscle cancer	0.000182	0.00231	CcSEcCtD
Ethinyl Estradiol—Malnutrition—Doxorubicin—muscle cancer	0.000182	0.00231	CcSEcCtD
Ethinyl Estradiol—Rash—Etoposide—muscle cancer	0.000181	0.00229	CcSEcCtD
Ethinyl Estradiol—Dermatitis—Etoposide—muscle cancer	0.000181	0.00229	CcSEcCtD
Ethinyl Estradiol—Headache—Etoposide—muscle cancer	0.00018	0.00228	CcSEcCtD
Ethinyl Estradiol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.000178	0.00226	CcSEcCtD
Ethinyl Estradiol—Discomfort—Methotrexate—muscle cancer	0.000177	0.00224	CcSEcCtD
Ethinyl Estradiol—Back pain—Doxorubicin—muscle cancer	0.000176	0.00223	CcSEcCtD
Ethinyl Estradiol—Muscle spasms—Doxorubicin—muscle cancer	0.000175	0.00222	CcSEcCtD
Ethinyl Estradiol—ESR2—SIDS Susceptibility Pathways—TP73—muscle cancer	0.000173	0.0235	CbGpPWpGaD
Ethinyl Estradiol—Infection—Methotrexate—muscle cancer	0.000171	0.00216	CcSEcCtD
Ethinyl Estradiol—Nausea—Etoposide—muscle cancer	0.00017	0.00216	CcSEcCtD
Ethinyl Estradiol—Ill-defined disorder—Doxorubicin—muscle cancer	0.000169	0.00214	CcSEcCtD
Ethinyl Estradiol—Nervous system disorder—Methotrexate—muscle cancer	0.000169	0.00213	CcSEcCtD
Ethinyl Estradiol—Skin disorder—Methotrexate—muscle cancer	0.000167	0.00211	CcSEcCtD
Ethinyl Estradiol—Malaise—Doxorubicin—muscle cancer	0.000164	0.00208	CcSEcCtD
Ethinyl Estradiol—Cough—Doxorubicin—muscle cancer	0.000159	0.00202	CcSEcCtD
Ethinyl Estradiol—Anxiety—Doxorubicin—muscle cancer	0.000155	0.00196	CcSEcCtD
Ethinyl Estradiol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.000154	0.00195	CcSEcCtD
Ethinyl Estradiol—Discomfort—Doxorubicin—muscle cancer	0.000153	0.00194	CcSEcCtD
Ethinyl Estradiol—Oedema—Doxorubicin—muscle cancer	0.000149	0.00188	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000148	0.00188	CcSEcCtD
Ethinyl Estradiol—Fatigue—Methotrexate—muscle cancer	0.000148	0.00188	CcSEcCtD
Ethinyl Estradiol—Infection—Doxorubicin—muscle cancer	0.000148	0.00187	CcSEcCtD
Ethinyl Estradiol—Nervous system disorder—Doxorubicin—muscle cancer	0.000146	0.00185	CcSEcCtD
Ethinyl Estradiol—Skin disorder—Doxorubicin—muscle cancer	0.000145	0.00183	CcSEcCtD
Ethinyl Estradiol—ABCC2—Constitutive Androstane Receptor Pathway—FOXO1—muscle cancer	0.000142	0.0194	CbGpPWpGaD
Ethinyl Estradiol—Feeling abnormal—Methotrexate—muscle cancer	0.000142	0.00179	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal pain—Methotrexate—muscle cancer	0.000141	0.00178	CcSEcCtD
Ethinyl Estradiol—Urticaria—Methotrexate—muscle cancer	0.000137	0.00173	CcSEcCtD
Ethinyl Estradiol—Abdominal pain—Methotrexate—muscle cancer	0.000136	0.00172	CcSEcCtD
Ethinyl Estradiol—Body temperature increased—Methotrexate—muscle cancer	0.000136	0.00172	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.000129	0.00163	CcSEcCtD
Ethinyl Estradiol—Fatigue—Doxorubicin—muscle cancer	0.000128	0.00163	CcSEcCtD
Ethinyl Estradiol—ESR1—Regulation of Telomerase—WT1—muscle cancer	0.000128	0.0174	CbGpPWpGaD
Ethinyl Estradiol—Constipation—Doxorubicin—muscle cancer	0.000127	0.00161	CcSEcCtD
Ethinyl Estradiol—Hypersensitivity—Methotrexate—muscle cancer	0.000127	0.0016	CcSEcCtD
Ethinyl Estradiol—Asthenia—Methotrexate—muscle cancer	0.000123	0.00156	CcSEcCtD
Ethinyl Estradiol—AOX1—Tryptophan metabolism—MDM2—muscle cancer	0.000123	0.0167	CbGpPWpGaD
Ethinyl Estradiol—Feeling abnormal—Doxorubicin—muscle cancer	0.000123	0.00155	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000122	0.00154	CcSEcCtD
Ethinyl Estradiol—Pruritus—Methotrexate—muscle cancer	0.000122	0.00154	CcSEcCtD
Ethinyl Estradiol—ESR1—Regulation of nuclear SMAD2/3 signaling—MYOD1—muscle cancer	0.00012	0.0163	CbGpPWpGaD
Ethinyl Estradiol—Urticaria—Doxorubicin—muscle cancer	0.000118	0.0015	CcSEcCtD
Ethinyl Estradiol—Abdominal pain—Doxorubicin—muscle cancer	0.000118	0.00149	CcSEcCtD
Ethinyl Estradiol—Body temperature increased—Doxorubicin—muscle cancer	0.000118	0.00149	CcSEcCtD
Ethinyl Estradiol—Diarrhoea—Methotrexate—muscle cancer	0.000118	0.00149	CcSEcCtD
Ethinyl Estradiol—Dizziness—Methotrexate—muscle cancer	0.000114	0.00144	CcSEcCtD
Ethinyl Estradiol—ESR2—Integrated Pancreatic Cancer Pathway—WT1—muscle cancer	0.000111	0.0151	CbGpPWpGaD
Ethinyl Estradiol—Hypersensitivity—Doxorubicin—muscle cancer	0.00011	0.00139	CcSEcCtD
Ethinyl Estradiol—Vomiting—Methotrexate—muscle cancer	0.000109	0.00138	CcSEcCtD
Ethinyl Estradiol—Rash—Methotrexate—muscle cancer	0.000108	0.00137	CcSEcCtD
Ethinyl Estradiol—Dermatitis—Methotrexate—muscle cancer	0.000108	0.00137	CcSEcCtD
Ethinyl Estradiol—Headache—Methotrexate—muscle cancer	0.000108	0.00136	CcSEcCtD
Ethinyl Estradiol—Asthenia—Doxorubicin—muscle cancer	0.000107	0.00135	CcSEcCtD
Ethinyl Estradiol—Pruritus—Doxorubicin—muscle cancer	0.000105	0.00133	CcSEcCtD
Ethinyl Estradiol—Nausea—Methotrexate—muscle cancer	0.000102	0.00129	CcSEcCtD
Ethinyl Estradiol—Diarrhoea—Doxorubicin—muscle cancer	0.000102	0.00129	CcSEcCtD
Ethinyl Estradiol—Dizziness—Doxorubicin—muscle cancer	9.84e-05	0.00125	CcSEcCtD
Ethinyl Estradiol—Vomiting—Doxorubicin—muscle cancer	9.47e-05	0.0012	CcSEcCtD
Ethinyl Estradiol—Rash—Doxorubicin—muscle cancer	9.39e-05	0.00119	CcSEcCtD
Ethinyl Estradiol—Dermatitis—Doxorubicin—muscle cancer	9.38e-05	0.00119	CcSEcCtD
Ethinyl Estradiol—Headache—Doxorubicin—muscle cancer	9.33e-05	0.00118	CcSEcCtD
Ethinyl Estradiol—CYP2B6—Constitutive Androstane Receptor Pathway—FOXO1—muscle cancer	9.08e-05	0.0123	CbGpPWpGaD
Ethinyl Estradiol—Nausea—Doxorubicin—muscle cancer	8.84e-05	0.00112	CcSEcCtD
Ethinyl Estradiol—ESR1—Regulation of nuclear SMAD2/3 signaling—FOXO4—muscle cancer	8.15e-05	0.0111	CbGpPWpGaD
Ethinyl Estradiol—ESR2—Integrated Pancreatic Cancer Pathway—BUB1B—muscle cancer	8.14e-05	0.0111	CbGpPWpGaD
Ethinyl Estradiol—NR1I2—Generic Transcription Pathway—MED12—muscle cancer	7.73e-05	0.0105	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—muscle cancer	7.11e-05	0.00966	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling mediated by p38-alpha and p38-beta—PTGS2—muscle cancer	6.82e-05	0.00927	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Constitutive Androstane Receptor Pathway—FOXO1—muscle cancer	6.7e-05	0.00911	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Leptin signaling pathway—FOXO1—muscle cancer	6.4e-05	0.00871	CbGpPWpGaD
Ethinyl Estradiol—ESR1—FOXM1 transcription factor network—CDKN2A—muscle cancer	6.3e-05	0.00857	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Regulation of nuclear SMAD2/3 signaling—FOXO1—muscle cancer	6.02e-05	0.00819	CbGpPWpGaD
Ethinyl Estradiol—SLC10A1—Metabolism of lipids and lipoproteins—MED12—muscle cancer	5.79e-05	0.00788	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Integrated Pancreatic Cancer Pathway—WT1—muscle cancer	5.61e-05	0.00763	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Aryl Hydrocarbon Receptor—PTGS2—muscle cancer	5.48e-05	0.00745	CbGpPWpGaD
Ethinyl Estradiol—ESR2—Generic Transcription Pathway—MED12—muscle cancer	5.44e-05	0.0074	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling by ERBB4—FOXO4—muscle cancer	4.93e-05	0.0067	CbGpPWpGaD
Ethinyl Estradiol—SLC10A1—Metabolism—FH—muscle cancer	4.57e-05	0.00621	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Aryl Hydrocarbon Receptor—VEGFA—muscle cancer	4.31e-05	0.00587	CbGpPWpGaD
Ethinyl Estradiol—ESR1—AP-1 transcription factor network—CDKN2A—muscle cancer	4.19e-05	0.00569	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Constitutive Androstane Receptor Pathway—FOXO1—muscle cancer	4.13e-05	0.00561	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Integrated Pancreatic Cancer Pathway—BUB1B—muscle cancer	4.1e-05	0.00558	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—muscle cancer	4.06e-05	0.00552	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Metabolism—FH—muscle cancer	3.93e-05	0.00534	CbGpPWpGaD
Ethinyl Estradiol—NR1I2—Gene Expression—MED12—muscle cancer	3.72e-05	0.00506	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Integrated Breast Cancer Pathway—FOXO1—muscle cancer	3.66e-05	0.00497	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling by ERBB4—FOXO1—muscle cancer	3.64e-05	0.00495	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—muscle cancer	3.63e-05	0.00493	CbGpPWpGaD
Ethinyl Estradiol—ESR2—Integrated Pancreatic Cancer Pathway—MDM2—muscle cancer	3.61e-05	0.00491	CbGpPWpGaD
Ethinyl Estradiol—ESR2—Integrated Pancreatic Cancer Pathway—PTGS2—muscle cancer	3.48e-05	0.00473	CbGpPWpGaD
Ethinyl Estradiol—ESR1—LKB1 signaling events—TP53—muscle cancer	3.44e-05	0.00468	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism of lipids and lipoproteins—MED12—muscle cancer	3.41e-05	0.00464	CbGpPWpGaD
Ethinyl Estradiol—ESR2—SIDS Susceptibility Pathways—VEGFA—muscle cancer	3.22e-05	0.00438	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Arachidonic acid metabolism—PTGS2—muscle cancer	3.11e-05	0.00423	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—muscle cancer	2.97e-05	0.00404	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling by ERBB4—KIT—muscle cancer	2.77e-05	0.00377	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Generic Transcription Pathway—MED12—muscle cancer	2.74e-05	0.00373	CbGpPWpGaD
Ethinyl Estradiol—ESR2—Integrated Pancreatic Cancer Pathway—VEGFA—muscle cancer	2.74e-05	0.00373	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism—FH—muscle cancer	2.69e-05	0.00366	CbGpPWpGaD
Ethinyl Estradiol—ESR2—Gene Expression—MED12—muscle cancer	2.62e-05	0.00356	CbGpPWpGaD
Ethinyl Estradiol—SLC10A1—Metabolism—MED12—muscle cancer	2.58e-05	0.00351	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—ENO2—muscle cancer	2.42e-05	0.00328	CbGpPWpGaD
Ethinyl Estradiol—SLC10A1—Metabolism—ENO2—muscle cancer	2.35e-05	0.0032	CbGpPWpGaD
Ethinyl Estradiol—ESR1—AP-1 transcription factor network—TP53—muscle cancer	2.33e-05	0.00317	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Metabolism—MED12—muscle cancer	2.22e-05	0.00302	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Integrated Breast Cancer Pathway—MDM2—muscle cancer	2.2e-05	0.00299	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—HMGA1—muscle cancer	2.19e-05	0.00298	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling by ERBB4—MDM2—muscle cancer	2.18e-05	0.00297	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—BUB1B—muscle cancer	2.17e-05	0.00295	CbGpPWpGaD
Ethinyl Estradiol—ESR2—Integrated Pancreatic Cancer Pathway—TP53—muscle cancer	2.07e-05	0.00281	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Metabolism—ENO2—muscle cancer	2.02e-05	0.00275	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—FOXO4—muscle cancer	1.97e-05	0.00268	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—KIDINS220—muscle cancer	1.89e-05	0.00256	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Tryptophan metabolism—MDM2—muscle cancer	1.85e-05	0.00252	CbGpPWpGaD
Ethinyl Estradiol—SLC10A1—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	1.84e-05	0.0025	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Integrated Pancreatic Cancer Pathway—MDM2—muscle cancer	1.82e-05	0.00247	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—muscle cancer	1.75e-05	0.00238	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—HIF-1-alpha transcription factor network—VEGFA—muscle cancer	1.71e-05	0.00233	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Integrated Breast Cancer Pathway—VEGFA—muscle cancer	1.67e-05	0.00227	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism—MED12—muscle cancer	1.52e-05	0.00207	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Allograft Rejection—VEGFA—muscle cancer	1.48e-05	0.00201	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—FOXO1—muscle cancer	1.45e-05	0.00198	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism of lipids and lipoproteins—MED12—muscle cancer	1.4e-05	0.0019	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism—ENO2—muscle cancer	1.39e-05	0.00189	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—muscle cancer	1.38e-05	0.00188	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Gene Expression—MED12—muscle cancer	1.32e-05	0.0018	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—FH—muscle cancer	1.3e-05	0.00177	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Integrated Breast Cancer Pathway—TP53—muscle cancer	1.26e-05	0.00171	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—KIT—muscle cancer	1.11e-05	0.00151	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—FH—muscle cancer	1.1e-05	0.0015	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	1.08e-05	0.00147	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Integrated Pancreatic Cancer Pathway—TP53—muscle cancer	1.04e-05	0.00142	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—muscle cancer	9.62e-06	0.00131	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—FH—muscle cancer	9.62e-06	0.00131	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—muscle cancer	9.28e-06	0.00126	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—MDM2—muscle cancer	8.73e-06	0.00119	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—PTGS2—muscle cancer	8.41e-06	0.00114	CbGpPWpGaD
Ethinyl Estradiol—SLC10A1—Metabolism—PTGS2—muscle cancer	8.19e-06	0.00111	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—PTCH1—muscle cancer	7.42e-06	0.00101	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—MED12—muscle cancer	7.37e-06	0.001	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—muscle cancer	7.31e-06	0.000994	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Metabolism—PTGS2—muscle cancer	7.04e-06	0.000958	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—ENO2—muscle cancer	6.72e-06	0.000913	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—FOXO4—muscle cancer	6.38e-06	0.000868	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—CNR1—muscle cancer	6.26e-06	0.000852	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—MED12—muscle cancer	6.24e-06	0.000848	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—FH—muscle cancer	5.92e-06	0.000806	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—ENO2—muscle cancer	5.69e-06	0.000773	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—muscle cancer	5.52e-06	0.000751	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—MED12—muscle cancer	5.43e-06	0.000739	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—IGF2—muscle cancer	5.12e-06	0.000697	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—ENO2—muscle cancer	4.95e-06	0.000674	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism—PTGS2—muscle cancer	4.83e-06	0.000657	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—FOXO1—muscle cancer	4.71e-06	0.000641	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	4.45e-06	0.000605	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—KIT—muscle cancer	3.59e-06	0.000488	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—MED12—muscle cancer	3.35e-06	0.000455	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—ENO2—muscle cancer	3.05e-06	0.000415	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—MDM2—muscle cancer	2.83e-06	0.000385	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—PTGS2—muscle cancer	2.34e-06	0.000318	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—VEGFA—muscle cancer	2.15e-06	0.000292	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—PTGS2—muscle cancer	1.98e-06	0.000269	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—PTGS2—muscle cancer	1.73e-06	0.000235	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—TP53—muscle cancer	1.62e-06	0.000221	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—PTGS2—muscle cancer	1.06e-06	0.000145	CbGpPWpGaD
